These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 21068204)

  • 61. Is Swedish snus associated with smoking initiation or smoking cessation?
    Furberg H; Bulik CM; Lerman C; Lichtenstein P; Pedersen NL; Sullivan PF
    Tob Control; 2005 Dec; 14(6):422-4. PubMed ID: 16319367
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Nicotine delivery, cardiovascular profile, and subjective effects of an oral tobacco product for smokers.
    Blank MD; Sams C; Weaver MF; Eissenberg T
    Nicotine Tob Res; 2008 Mar; 10(3):417-21. PubMed ID: 18324559
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Anxiety Sensitivity and Distress Tolerance in Smokers: Relations With Tobacco Dependence, Withdrawal, and Quitting Success†.
    Schlam TR; Baker TB; Smith SS; Cook JW; Piper ME
    Nicotine Tob Res; 2020 Jan; 22(1):58-65. PubMed ID: 31056710
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Mass Spectrometric Quantitation of
    Li Y; Hecht SS
    Chem Res Toxicol; 2022 Sep; 35(9):1579-1588. PubMed ID: 36006857
    [No Abstract]   [Full Text] [Related]  

  • 67. Exposure to nicotine and a tobacco-specific carcinogen increase with duration of use of smokeless tobacco.
    Hecht SS; Carmella SG; Edmonds A; Murphy SE; Stepanov I; Luo X; Hatsukami DK
    Tob Control; 2008 Apr; 17(2):128-31. PubMed ID: 18375734
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Quantitation of metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone after cessation of smokeless tobacco use.
    Hecht SS; Carmella SG; Ye M; Le KA; Jensen JA; Zimmerman CL; Hatsukami DK
    Cancer Res; 2002 Jan; 62(1):129-34. PubMed ID: 11782369
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Successful Nicotine Intake in Medical Assisted Use of E-Cigarettes: A Pilot Study.
    Pacifici R; Pichini S; Graziano S; Pellegrini M; Massaro G; Beatrice F
    Int J Environ Res Public Health; 2015 Jul; 12(7):7638-46. PubMed ID: 26184244
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Insula-specific H magnetic resonance spectroscopy reactions in heavy smokers under acute nicotine withdrawal and after oral nicotine substitution.
    Gutzeit A; Froehlich JM; Hergan K; Graf N; Binkert CA; Meier D; Brügger M; Reischauer C; Sutter R; Herdener M; Schubert T; Kos S; Grosshans M; Straka M; Mutschler J
    Eur Addict Res; 2013; 19(4):184-93. PubMed ID: 23257512
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Population-based survey of cessation aids used by Swedish smokers.
    Rutqvist LE
    Harm Reduct J; 2012 Dec; 9():38. PubMed ID: 23206988
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Monitoring tobacco-specific N-nitrosamines and nicotine in novel smokeless tobacco products: findings from round II of the new product watch.
    Stepanov I; Biener L; Yershova K; Nyman AL; Bliss R; Parascandola M; Hatsukami DK
    Nicotine Tob Res; 2014 Aug; 16(8):1070-8. PubMed ID: 24604020
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Exposure to nicotine and carcinogens among Southwestern Alaskan Native cigarette smokers and smokeless tobacco users.
    Benowitz NL; Renner CC; Lanier AP; Tyndale RF; Hatsukami DK; Lindgren B; Stepanov I; Watson CH; Sosnoff CS; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2012 Jun; 21(6):934-42. PubMed ID: 22490317
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Tobacco specific nitrosamines and potential reduced exposure products for smokers: a preliminary evaluation of Advance.
    Breland AB; Acosta MC; Eissenberg T
    Tob Control; 2003 Sep; 12(3):317-21. PubMed ID: 12958395
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Varying nicotine patch dose and type of smoking cessation counseling.
    Jorenby DE; Smith SS; Fiore MC; Hurt RD; Offord KP; Croghan IT; Hays JT; Lewis SF; Baker TB
    JAMA; 1995 Nov; 274(17):1347-52. PubMed ID: 7563558
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nicotine delivery and subjective effects of Swedish portion snus compared with 4 mg nicotine polacrilex chewing gum.
    Lunell E; Curvall M
    Nicotine Tob Res; 2011 Jul; 13(7):573-8. PubMed ID: 21454913
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Effects of high dose transdermal nicotine replacement in cigarette smokers.
    Hatsukami D; Mooney M; Murphy S; LeSage M; Babb D; Hecht S
    Pharmacol Biochem Behav; 2007 Jan; 86(1):132-9. PubMed ID: 17267026
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identification of tobacco-derived compounds in human pancreatic juice.
    Prokopczyk B; Hoffmann D; Bologna M; Cunningham AJ; Trushin N; Akerkar S; Boyiri T; Amin S; Desai D; Colosimo S; Pittman B; Leder G; Ramadani M; Henne-Bruns D; Beger HG; El-Bayoumy K
    Chem Res Toxicol; 2002 May; 15(5):677-85. PubMed ID: 12018989
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Comparison of consumption patterns, biomarkers of exposure, and subjective effects in cigarette smokers who switched to dissolvable tobacco (Camel Orbs), dual use, or tobacco abstinence.
    Krautter GR; Borgerding MF
    Nicotine Tob Res; 2014 Oct; 16(10):1336-47. PubMed ID: 24879304
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Timing of nicotine lozenge administration to minimize trigger induced craving and withdrawal symptoms.
    Kotlyar M; Lindgren BR; Vuchetich JP; Le C; Mills AM; Amiot E; Hatsukami DK
    Addict Behav; 2017 Aug; 71():18-24. PubMed ID: 28235705
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.